Inspire Medical Systems annual gross margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
Inspire Medical Systems's gross margin was 85.39% for fiscal 2025.
View full Inspire Medical Systems company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 85.39% | +0.71 pp |
| 2024 | 2024-12-31 | 84.68% | +0.14 pp |
| 2023 | 2023-12-31 | 84.54% | +0.75 pp |
| 2022 | 2022-12-31 | 83.79% | −1.95 pp |
| 2021 | 2021-12-31 | 85.74% | +1.02 pp |
| 2020 | 2020-12-31 | 84.73% | +1.35 pp |
| 2019 | 2019-12-31 | 83.37% | +3.25 pp |
| 2018 | 2019-01-01 | 80.12% | +1.19 pp |
| 2017 | 2017-12-31 | 78.93% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 85.48% | +1.45 pp |
| Q1 2026 | 2026-03-31 | 86.47% | +1.73 pp |
| Q4 2025 | 2025-12-31 | 86.59% | +1.61 pp |
| Q3 2025 | 2025-09-30 | 85.85% | +1.79 pp |
| Q2 2025 | 2025-06-30 | 84.03% | −0.74 pp |
| Q1 2025 | 2025-03-31 | 84.75% | −0.16 pp |
| Q4 2024 | 2024-12-31 | 84.99% | −0.44 pp |
| Q3 2024 | 2024-09-30 | 84.06% | −0.04 pp |
| Q2 2024 | 2024-06-30 | 84.77% | +0.82 pp |
| Q1 2024 | 2024-03-31 | 84.91% | +0.46 pp |
| Q4 2023 | 2023-12-31 | 85.43% | +1.49 pp |
| Q3 2023 | 2023-09-30 | 84.10% | +2.22 pp |
| Q2 2023 | 2023-06-30 | 83.95% | −0.54 pp |
| Q1 2023 | 2023-03-31 | 84.45% | −1.13 pp |
| Q4 2022 | 2022-12-31 | 83.94% | −1.83 pp |
| Q3 2022 | 2022-09-30 | 81.88% | −4.14 pp |
| Q2 2022 | 2022-06-30 | 84.49% | −1.31 pp |
| Q1 2022 | 2022-03-31 | 85.58% | +0.40 pp |
| Q4 2021 | 2021-12-31 | 85.77% | +1.33 pp |
| Q3 2021 | 2021-09-30 | 86.02% | +0.56 pp |
| Q2 2021 | 2021-06-30 | 85.80% | +1.84 pp |
| Q1 2021 | 2021-03-31 | 85.18% | +0.62 pp |
| Q4 2020 | 2020-12-31 | 84.44% | +0.19 pp |
| Q3 2020 | 2020-09-30 | 85.46% | +2.03 pp |
| Q2 2020 | 2020-06-30 | 83.96% | +1.12 pp |
| Q1 2020 | 2020-03-31 | 84.56% | +2.12 pp |
| Q4 2019 | 2019-12-31 | 84.25% | +3.53 pp |
| Q3 2019 | 2019-09-30 | 83.43% | +2.33 pp |
| Q2 2019 | 2019-06-30 | 82.84% | +2.06 pp |
| Q1 2019 | 2019-03-31 | 82.44% | +5.28 pp |
| Q4 2018 | 2019-01-01 | 80.72% | −0.39 pp |
| Q3 2018 | 2018-09-30 | 81.10% | +2.63 pp |
| Q2 2018 | 2018-06-30 | 80.78% | +3.56 pp |
| Q1 2018 | 2018-03-31 | 77.16% | −0.27 pp |
| Q4 2017 | 2017-12-31 | 81.11% | — |
| Q3 2017 | 2017-09-30 | 78.48% | — |
| Q2 2017 | 2017-06-30 | 77.23% | — |
| Q1 2017 | 2017-03-31 | 77.42% | — |
Over the last five reported fiscal years, Inspire Medical Systems's gross margin increased from 84.73% to 85.39%, a change of +0.67 percentage points. The latest reported quarter, Q2 2026, shows 85.48%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inspire Medical Systems filings at SEC.gov ↗